Moderna rises after FDA grants limited approval for next-gen Covid vaccine
rose about 4% in early trading after the Food and Drug Administration granted limited approval for its new COVID-19 vaccine. The FDA approved Moderna’s second-generation vaccine for all adults over 65...
Regeneron, Sanofi slump after late-stage trials for “smoker’s lung” drug disappoint
and fell in early trading after a pair of key trials on their “smoker’s lung” drug showed mixed results. The companies announced Friday morning that Itepekimab, an experimental drug meant to treat ch...
Drugmakers beg Trump administration to rethink pharma tariffs
Drugmakers implored the US Department of Commerce to rethink its proposal to impose tariffs on imported pharmaceuticals. Last month, the Trump administration launched an investigation into the nationa...
RFK: Covid jab not recommended for healthy children, pregnant people
Health and Human Services Secretary Robert F. Kennedy Jr. said Tuesday that the COVID-19 shot is no longer on the country’s recommended vaccine list for healthy children and pregnant people. The new s...
Novo Nordisk’s weight-loss drug sales are slumping so much that the entire nation of Denmark could see an export slowdown
Sales of obesity drugs have slowed to the point that the company’s home country, Denmark, sees an export slowdown on the horizon. The Danish Economic Councils, the country’s economic watchdog, releas...
Wegovy goes on sale after off-ramp for copycats ends
Wegovy, the blockbuster weight-loss jab made by , is on sale. As of Thursday, compounding pharmacies can no longer sell exact copies of semaglutide, the active ingredient in Wegovy and its better-know...
Wall Street has cut its UnitedHealth EPS forecasts by >20% for each of the next 3 years
UnitedHealth has been rocked by negative headline after negative headline in the last five weeks, with yesterday’s latest — a report that alleged it coordinated with nursing homes to reduce hospitaliz...
Hims slumps after Cigna expands GLP-1 access
sank more than 9% in premarket trading as its grip on one of its most lucrative revenue streams seems to be slipping. On Wednesday, pharmacy benefit manager, Evernorth, announced a plan to cap copays...
The cutoff day for copycat Ozempic and Wegovy is imminent. What’s next?
Pharmacies that sell compounded semaglutide, the active ingredient in Ozempic and Wegovy, will have to stop making exact copies after Thursday, throwing a wrench in the business models of telehealth c...
Move over Tesla, UnitedHealth is the battleground stock for retail traders this week as options trading explodes
Retail darlings like , , and have had to make way for a new battleground stock on popular investing forums in the last week: embattled stock . After the shooting of its CEO last year, America’s large...
Moderna rises on FDA Covid vaccine guidance that doesn’t destroy its core business
jumped on Tuesday after the Food and Drug Administration approved its COVID-19 booster shot for people 65 and older or with high-risk conditions. FDA officials said in the New England Journal of Medic...
What Regeneron’s purchase of 23andMe means for the millions of people’s DNA it now owns
A pharmaceutical company that specializes in making DNA-based research agreed to buy out of bankruptcy, averting a worst-case scenario as the genetic data of millions of consumers was auctioned off. ...
23andMe sells DNA database for $256 million to biotech giant Regeneron
23andMe is selling its prized DNA testing data bank to drugmaker for $256 million as part of its bankruptcy asset sale. The trove includes genetic data from more than 15 million customer DNA samples....
Europe’s most valuable company, SAP, is only extending its lead
Since dethroning as Europe’s most valuable company back in March , German software giant SAP has gone from strength to strength — while the Danish Ozempic maker has sunk further in the face of tariff...
Novavax climbs after its Covid jab gets FDA approval
American vaccine maker rose more than 20% in early trading on Monday after it announced that the Food and Drug Administration fully approved its COVID-19 vaccine, Nuvaxovid. Nuvaxovid is the only pro...
Ozempic maker Novo Nordisk pushes out its CEO over declining stock price
announced on Friday that it would replace its CEO, Lars Fruergaard Jørgensen, as the company’s stock price slips amid fierce competition for new weight-loss drugs. The company said the decision was ma...
Pharma stocks under pressure as Trump plans executive order to lower drug prices
The Trump administration is definitely on a low prices kick this morning (or at least, prices-not-as-high-as-they-could’ve-been). But while most of the market is cheering because the US and China have...
Novo Nordisk shares rise as the company expects weight-loss drug competition to subside
The Danish pharma giant just cut its full-year sales and profit guidance for the first time since it launched Wegovy in 2021, with similar drugs from competitors eating into its US market share. Howev...
Hims soars after “choose-your-own-adventure” earnings report
rose more than 17% on Tuesday after whipsawing in after-hours trading Monday evening as investors digested a nuanced earnings report . The results had a mix of good and bad news, giving both bears and...
Pharma imports surged this year as drugmakers grapple with tariff threats
The US imported $20 billion more pharmaceutical products in the first three months of 2025 than it did during the same period last year as drugmakers grapple with the unprecedented threat of import ta...